U.S. stocks were down slightly on Tuesday as investors weighed the impact of tariffs, with U.S. President Donald Trump saying ...

SBI warns that a 50 per c US tariff on Indian pharma exports could cut earnings by 10 in FY26, hitting firms reliant on the US for up to 50 per cent revenue.

How could higher U.S. tariffs on Indian pharmaceutical products impact drug stocks? Seeking Alpha analysts weigh in. Read ...

Analysis by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern.

Explore the US escalating tariffs on India, from 'Tariff King' to 50% duties. Impact on exports, sectors, and trade relations ...

President Donald Trump provided new details about his plan to impose tariffs on foreign-made pharmaceuticals, but the White ...

The impact on innovator contract research, development and manufacturing organisations (CRDMOs) would be relatively lower ...

President Trump's plan to levy tariffs on imported pharmaceuticals is drawing criticism from all sides of the political ...

With the new US tariffs imposed by Donald Trump, India will have to pay a 50% import tariff on most of its goods. The ...

The US move to impose new tariffs on Indian goods could affect nearly 50% of India’s $86 billion exports, hitting sectors ...

India, one of the largest suppliers of generic medicines to the U.S., is expected to be significantly impacted. According to ...